We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




The Tumor Suppressor Pannexin1 Modulates Intercellular Binding

By LabMedica International staff writers
Posted on 21 Feb 2012
Print article
A novel three-dimensional growth chamber was used to determine how the tumor-suppressive protein Pannexin 1 (Panx1) functions to maintain cellular aggregates and reduce the likelihood of cancer progression.

Investigators at Brown University (Providence, RI, USA) worked with cultures of rat C6 glioma cells. These cells normally lack functioning Panx1. However, for this study, some C6 cells were genetically engineered to express Panx1.

The cells were cultured in novel three-dimensional growth chambers that provided them with a microenvironment that closely mimicked that found in vivo. Results published in the January 20, 2012, online edition of the Journal of Biological Chemistry revealed that after 24 hours in the growth chambers, cells with active Panx1 were able to form large multicellular tissues much faster and more tightly than the unaltered cancer cells.

Treatment with the drugs carbenoxolone (CBX) and probenecid (PBN), which directly and specifically block Panx1 channels respectively, confirmed that Panx1 was involved in accelerating aggregate assembly, and that exogenous ATP could reverse the inhibitive effects of CBX. These results indicated that Panx1 channels acted as conduits for ATP secretion that stimulated molecular pathways in the cell membrane linked to formation of stable intercellular bonds.

“In healthy tissues, the recently discovered protein Pannexin1 may be playing an important role in upholding the mechanical integrity of the tissue,” said first Brian Bao, doctoral student at Brown University. “When we develop cancer, we lose Pannexin1 and we lose this integrity. Using their single-cell systems, others have been able to carefully study individual pieces of this cascade. We came from a different perspective. Because the strength of our assay is that we can look at gross multicellular behavior in 3-D, we could ask, ‘Does this actually manifest into something tangible on the multicellular level?’

Related Links:

Brown University

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.